Arkolith/Insider Trading/CYT/Form 4

Renschler Markus MD

President and CEO, DirectorCyteir Therapeutics, Inc. (CYT) · full profile →Form 4 · filed Dec 23, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 21, 2022Option exercise(M)106K$1.03$110K948K
Dec 21, 2022Option exercise(M)30K$1.20$37K979K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 21, 2022Option exercise(M)30K—$033K
Dec 21, 2022Option exercise(M)106K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-062627) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML